Aspen Group to Present at the 30th Annual Roth Conference
Mar 06, 2018 21:01 pm UTC| Business
NEW YORK, March 06, 2018 -- Aspen Group, Inc. (Nasdaq:ASPU), a post-secondary education company, today announced that its management is scheduled to participate in the 30th Annual ROTH Conference on March 13, 2018. ...
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
Mar 06, 2018 21:01 pm UTC| Business
EDIT-101 for Leber Congenital Amaurosis type 10 (LCA10) on track for mid-2018 Investigational New Drug (IND) filing Expecting at least five clinical-stage programs by end of 2022 as part of EM22 five-year goals Year-end...
Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 06, 2018 21:01 pm UTC| Business
PLANO, Texas, March 06, 2018 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year ended December 31, 2017. Recent...
Clearside Announces Proposed Public Offering of Common Stock
Mar 06, 2018 21:01 pm UTC| Business
ALPHARETTA, Ga., March 06, 2018 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced...
Mar 06, 2018 21:01 pm UTC| Business
WASHINGTON, March 06, 2018 -- The founding members of the National Coordination Center's Department of Veterans Affairs (VA) Steering Committee today announced their commitment to help support the VA’s 10-year...
T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
Mar 06, 2018 21:01 pm UTC| Business
LEXINGTON, Mass., March 06, 2018 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare,...
Mar 06, 2018 21:00 pm UTC| Business
Freehold, N.J., March 06, 2018 -- Jensyn Acquisition Corp. (NASDAQ:JSYN) (“Jensyn Acquisition” or the “Company”), a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other...